# An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis

> **NCT03943147** · PHASE2 · TERMINATED · sponsor: **Bristol-Myers Squibb** · enrollment: 16 (actual)

## Conditions studied

- Lupus Nephritis

## Interventions

- **DRUG:** BMS-986165
- **DRUG:** Placebo
- **DRUG:** Mycophenolate Mofetil

## Key facts

- **NCT ID:** NCT03943147
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-07-15
- **Primary completion:** 2020-10-29
- **Final completion:** 2021-09-17
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Insufficient enrollment
- **Last updated:** 2022-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03943147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03943147, "An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03943147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*